Understanding immune responses to improve vaccines and treatments for infectious diseases
NIH TETRAMER CORE FACILITY (HIV/AIDS)
This study is all about helping scientists learn more about how our immune system works, especially to create better vaccines and treatments for diseases like HIV/AIDS, so that patients can have improved health outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10222883 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of immune responses, particularly through the use of Major Histocompatibility Complex (MHC) tetramer reagents. These reagents are synthesized and distributed to researchers worldwide to aid in the development of vaccines and therapies for infectious and immune-mediated diseases. By providing essential resources and support, this initiative aims to facilitate advancements in public health and improve treatment outcomes for patients. The research is part of a broader effort to combat diseases like HIV/AIDS and enhance immune response knowledge.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by infectious diseases, particularly those related to HIV/AIDS.
Not a fit: Patients with non-infectious diseases or those not affected by immune-mediated conditions may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and therapies for infectious diseases, benefiting patients by enhancing their immune responses.
How similar studies have performed: Previous research utilizing MHC tetramer technology has shown promise in enhancing vaccine development and understanding immune responses, indicating a successful track record for similar approaches.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.